FTRE - Fortrea Holdings Inc.

10.38
-0.100   -0.963%

Share volume: 1,352,599
Last Updated: 03-04-2026
Healthcare/Services – Health: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$10.48
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
42%
Profitability 35%
Dept financing 34%
Liquidity 12%
Performance 59%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.70%
1 Month
-24.78%
3 Months
-27.11%
6 Months
-10.75%
1 Year
-4.68%
2 Year
-71.59%
Key data
Stock price
$10.38
P/E Ratio 
0.00
DAY RANGE
$10.14 - $10.76
EPS 
-$7.35
52 WEEK RANGE
$3.97 - $18.67
52 WEEK CHANGE
-$2.90
MARKET CAP 
1.594 B
YIELD 
N/A
SHARES OUTSTANDING 
93.500 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-11-2025
BETA 
2.21
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,087,846
AVERAGE 30 VOLUME 
$2,255,605
Company detail
CEO: Tom Pike
Region: US
Website: www.fortrea.com
Employees: 0
IPO year: 2023
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Fortrea is a leading global contract research organization (CRO) helping customers bring life-changing solutions to patients faster. With over 19,000 professionals conducting operations in more than 90 countries, Fortrea is transforming drug and device development for partners and patients across the globe.

Recent news